Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to see if people with reflux with a Zenker's diverticulum have increased reflux into the throat following a cricopharyngeal myotomy.


Clinical Trial Description

Gastroesophageal reflux is considered to be a common cause of cricopharyngeal dysfunction and Zenker's diverticulum. In patients with severe symptoms of dysphagia, we perform a cricopharyngeal myotomy to release the tension at the upper esophageal sphincter. There has been some speculation that if the upper esophageal sphincter is severed, there could be an increase in reflux into the pharyngeal and laryngeal structures. The current gold standard for measuring laryngopharyngeal reflux (LPR) is 24 hour monitoring with a dual-electrode pH catheter. A newer device specifically measures LPR by sitting in the nasopharynx. The probe has been verified as accurate by several studies, with some postulating that since its recording intervals are closer together, it may be more accurate for measuring LPR. We aim to measure LPR with the new pH probe in patients with gastroesophageal reflux before and after cricopharyngeal myotomy to see if LPR becomes present or worsens after surgery. All patients presenting with cricopharyngeal dysfunction or Zenker's diverticulum with a diagnosis or symptoms of gastroesophageal reflux or laryngopharyngeal reflux will be asked to participate in the study. If they meet the inclusion criteria, agree to participate, and wish to undergo surgery for their dysphagia, a baseline 24 hr laryngopharyngeal reflux study will be obtained using the Restech probe. Additionally, baseline dysphagia and reflux questionnaires will be obtained and an exam with flexible nasopharyngoscopy will be done. This exam is considered part of a standard exam for this condition and would be performed even if patients were not part of the research study. The surgical procedure will treat their dysphagia no differently than if they were not participating in the study. The patient will have their standard postoperative visit at 4 weeks, where their reflux and dysphagia symptoms will be assessed with questionnaires and a reflux finding score will be calculated via nasopharyngoscopy. At 3 months, an additional 24 laryngopharyngeal reflux study will be conducted with the Restech probe, and the patient will be seen in clinic for their final postoperative visit shortly thereafter. The questionnaires and the flexible nasopharyngoscopy for a reflux finding score will be repeated. The nasopharyngoscopy exam is standard of care for this patient visit. The patient would undergo the same number of nasopharyngoscopies even if they were not part of the study. During the study, if the patient is already on medication for reflux, they will be taken off their medication for 7 days in order to better detect changes in their LPR before and after cricopharyngeal myotomy. This is the standard protocol for patients being tested for LPR by the 24 hr pH probe study with the Restech probe. The patients will serve as their own controls as we are looking for significant increases in the amount of laryngopharyngeal reflux after cricopharyngeal myotomy. The data will be maintained in a database until the end of the study. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT01880892
Study type Interventional
Source Mayo Clinic
Contact
Status Completed
Phase N/A
Start date June 2013
Completion date January 2, 2018

See also
  Status Clinical Trial Phase
Recruiting NCT06205446 - Application of Diaphragmatic Breathing in Patients With Disorders of Gut-brain Interaction N/A
Completed NCT02552966 - Assessing the Impacts of a UESAD on Laryngeal Symptoms and Salivary Pepsin N/A
Completed NCT01450748 - Efficacy and Safety of Alginos Oral Suspension to Treat Laryngopharyngeal Reflux Phase 3
Recruiting NCT04827355 - Reflux Band in Laryngopharyngeal Reflux N/A
Not yet recruiting NCT03455803 - Effect of CPAP Therapy on LPR Among Patients With OSAS N/A
Withdrawn NCT02530879 - Comparison of Voice Therapy and Antireflex Therapy in LPR Phase 4
Completed NCT01854970 - Benefit of Pharyngeal and Oesophageal pH-impedance of Patients With High Suspicion of Laryngopharyngeal Reflux N/A
Completed NCT00321503 - Study of an Oropharyngeal Aerosolized pH Probe for Diagnosing Laryngopharyngeal Reflux (LPR) N/A
Terminated NCT01317472 - The Effects of Dexlansoprazole for the Treatment of Throat-Related Reflux N/A
Completed NCT02183961 - Three Methods Used in the Diagnosis of EER in Children With OME N/A
Not yet recruiting NCT01328652 - Dexlansoprazole to Treat Laryngopharyngeal Reflux and Lingual Tonsil Hypertrophy Phase 4
Not yet recruiting NCT04383262 - Lexiva for the Treatment of LPR Phase 3
Recruiting NCT04984304 - Individualized Diagnosis and Treatment of Extraesophageal Reflux in Patients With Chronic Cough N/A
Withdrawn NCT03463395 - Efficacy of Reza Band for the Treatment of Laryngopharyngeal Reflux N/A
Completed NCT00864396 - Twice Daily Prevacid for the Treatment of Laryngopharyngeal Reflux Phase 1
Completed NCT03619811 - Precision Approach to PPI Therapy in Gastroesophageal Reflux Disease N/A
Recruiting NCT05879029 - Clinical Study of Jinsang Liyan Capsules Combined With PPI in the Treatment of LPRD Phase 4
Recruiting NCT05204303 - LPR Fluorescence Pilot
Terminated NCT01777854 - Anti-reflux Control to Decrease Post Tonsillectomy Pain Phase 4
Withdrawn NCT01308502 - A New Nasopharyngeal pH Probe for Diagnosis of Laryngopharyngeal Reflux Phase 4